In this guide
What is fisetin?
Fisetin is a plant flavonol found in small amounts in foods including strawberries, apples and persimmons. Concentrated supplements are promoted for healthy aging because fisetin can alter senescence-related biology in selected experimental systems. It is not a vitamin, and food occurrence does not make a concentrated supplement equivalent to eating fruit. Its defined compound identity is catalogued separately from any efficacy claim. [4]
The influential 2018 paper tested senescent murine and human fibroblasts, human adipose-tissue explants and mice. It reported reduced senescence markers and longer mouse lifespan. Those findings justify clinical research, but they do not show that an oral fisetin supplement removes senescent cells, extends life or prevents disease in people. [2]
Evidence ladder
The senolytic story changes at each step
Movement up the ladder requires new human evidence; it cannot be assumed from the step below.
Typical Fisetin Protocols
| Study and population | Product | Amount each administration | Daily total | Frequency and duration | Main interpretation |
|---|---|---|---|---|---|
| Farsad-Naeimi 2018 · 37 colorectal-cancer patients receiving chemotherapy | Fisetin capsule | 100 mg | 100 mg | Once daily for 7 weeks; started 1 week before chemotherapy and continued through the second cycle | IL-8 was the clearest between-group signal; no healthy-aging or clinical-outcome endpoint |
This trial is often lost inside broad senolytic dose discussions. It evaluated continuous 100 mg/day exposure in a specific cancer-treatment setting. It did not test an intermittent gram-level pulse, healthy adults, senescent-cell clearance in tissue, longer life or protection from age-related disease. [3]
The absence of an established public pulse protocol is material. Translating a mouse amount by body weight, copying a trial registration without final results, or treating a commercial capsule schedule as clinical evidence can all create false precision. A 2024 review still lists human pharmacokinetics, safety, efficacy and dose optimization as open questions. [1]
Protocol boundary
A published schedule is not a universal regimen
Population, treatment context, formulation and outcome all travel with a protocol.
- Formulation
- Record the labeled fisetin amount and any delivery system; extract or blend mass is not automatically fisetin mass.
- Schedule
- Keep amount per administration, daily total, consecutive days and cycle interval in separate fields.
- Treatment context
- Cancer therapy, medicines, surgery and other longevity compounds can change the safety question.
What is fisetin commonly used for?
Senolytic and healthy-aging interest
Senescent cells stop dividing but can remain metabolically active and release signals associated with inflammation and tissue dysfunction. Fisetin changed senescence measures in selected cells, explants and mice, and improved lifespan measures in mice. It remains a candidate senotherapeutic rather than a proven human senolytic. [1], [2]
Inflammatory markers
In the 37-person colorectal-cancer trial, IL-8 fell more with fisetin than placebo. hs-CRP and MMP-7 changed within the fisetin group, but between-group interpretation was less convincing. A small biomarker study can show biological activity without proving improved symptoms, treatment response, recurrence, survival or longevity. [3]
Cognitive, metabolic and musculoskeletal claims
These claims largely draw on mechanisms, animal work or broader senolytic theory. They require their own finished human fisetin trials with prespecified outcomes. The 2024 review describes active translation, but it does not establish a general clinical use. [1]
How do forms and labels differ?
Standard capsules and powders may list fisetin as a single ingredient. Liposomal, phytosome, micronized and other delivery claims attempt to address poor water solubility, yet a claim of higher absorption does not prove a better clinical outcome. Check whether the label states fisetin mass per serving or only the mass of a proprietary complex.
Multi-ingredient “senolytic” products can include quercetin, resveratrol, spermidine or other compounds. They cannot inherit the evidence for purified fisetin, and they make adverse-effect attribution harder. Third-party identity and contaminant testing can improve confidence in what is in a bottle; it does not prove efficacy.
How should fisetin be stored?
Keep the finished product sealed, dry and away from heat and direct light. Follow the manufacturer’s temperature and expiry instructions, especially for lipid-delivery products. Do not use capsules after moisture, odor, discoloration or package damage. Record the brand, lot and label because formulation changes can matter.
What does the human evidence show?
| Question | Evidence | Finding | Boundary |
|---|---|---|---|
| Does fisetin affect senescence models? | 2018 primary paper | Activity in selected cells, explants and mice | Not a human oral clinical outcome |
| Does it extend lifespan? | Aged-mouse experiment | Mouse lifespan measures improved | No human lifespan trial |
| Is there direct human biological activity? | 37-person oncology RCT | IL-8 favored fisetin | Narrow population and biomarker |
| Is a healthy-aging regimen established? | 2024 review | Translation remains early | PK, efficacy, safety and dose remain open |
The evidence supports a research hypothesis, not a consumer promise. The preclinical program is broader than the completed direct human evidence. The small randomized trial is valuable because it tested oral fisetin in people, but its cancer-treatment setting and biomarker endpoint sharply limit generalization. [1]–[3]
Fisetin-specific healthy-adult data do not establish reduced frailty, dementia, cardiovascular events, disability or mortality. Registered trials and rationale papers show scientific interest; only completed and reported outcomes can answer whether a protocol works.
What are the risks and interactions?
Human safety reporting is too limited to define a universal upper limit or reliable long-term risk rate. Possible complaints in public use include stomach upset, headache and fatigue, but community reports cannot establish frequency or cause. Stop and seek urgent help for severe allergy, fainting, persistent vomiting or unusual bleeding.
Laboratory findings and flavonoid pharmacology raise questions about platelet function and drug-metabolizing pathways, but the size of clinical fisetin interactions is not well quantified. Review use with anticoagulant or antiplatelet medicines, before surgery, and with medicines that have narrow therapeutic margins.
The cancer trial does not mean fisetin is compatible with every chemotherapy regimen. Oncology treatment, radiation, immunotherapy, pregnancy, breastfeeding, liver or kidney disease, and planned surgery warrant clinician or pharmacist review. Do not use a supplement to replace or modify cancer treatment. [3], [5]
What is the legal and regulatory status?
In the United States, fisetin is generally sold as a dietary supplement. FDA does not preapprove dietary supplements as effective senolytic or anti-aging treatments, and disease-treatment claims raise a different regulatory issue. In Canada, an authorized natural health product should carry a matching NPN or DIN-HM and follow its licensed conditions. Market access in either country does not prove human longevity efficacy.
What happens when you stop?
Fisetin has no established withdrawal syndrome and no evidence-based taper. Because senolytic pulse schedules themselves remain unsettled, there is also no validated maintenance interval after stopping. Persistent or new symptoms deserve assessment rather than an assumption that they are “detox” or senescent-cell clearance.
What should you monitor?
Record product, labeled fisetin amount, delivery system, amount per administration, daily total, timing, cycle dates and co-ingredients. Define what is being observed before starting. Energy or soreness reports cannot substitute for objective clinical outcomes, and a short-term feeling does not verify senolysis.
Track GI symptoms, headache, fatigue, bruising or bleeding and the timing of medication or treatment changes. If a clinician is using laboratory monitoring, keep the agreed test, units and timing consistent. Do not add or stop cancer, anticoagulant, glucose-lowering or blood-pressure treatment based on a supplement log.
What does community experience add?
Public reports can identify questions worth studying: fatigue after a pulse, headache, stomach upset, cost, capsule burden and confusion over multi-ingredient stacks. They cannot verify product identity, senescent-cell clearance or long-term benefit. No systematic current community sample was assembled, so this guide reports no consensus dose, cycle, responder rate or brand.
How does fisetin compare with related options?
| Option | Practical distinction | Evidence boundary |
|---|---|---|
| Fisetin | Direct preclinical senotherapeutic program | Very limited direct human outcomes |
| Quercetin | Another flavonoid used alone and in drug-plus-flavonoid senolytic research | Dasatinib-plus-quercetin results do not transfer to fisetin |
| Resveratrol | Much larger and heterogeneous human trial literature | No established human longevity outcome |
| Spermidine | Dietary polyamine with a different autophagy-focused rationale | Requires its own intervention evidence |
| Fruit and vegetables | Food matrices with small variable fisetin amounts | Do not reproduce concentrated supplement protocols |
Common questions
Is fisetin proven to clear senescent cells in humans?
No. Selected cells, explants and mice support the hypothesis, but a validated human oral senescent-cell clearance outcome has not been established. [1], [2]
Does fisetin extend lifespan?
The 2018 paper reported lifespan effects in mice. There is no human trial showing longer life from fisetin. [2]
What dose was used in the direct human trial?
The 37-person colorectal-cancer study used 100 mg once daily for seven weeks. That schedule belongs to a chemotherapy adjunct trial and is not a general anti-aging recommendation. [3]
Is a gram-level two-day pulse validated?
No completed healthy-adult trial establishes a public self-care gram-level pulse regimen. Human dose optimization remains unresolved. [1]
Can fisetin be taken during chemotherapy?
Do not infer universal compatibility from one small adjunctive study. Regimens differ, and an oncologist or oncology pharmacist should review the exact product and treatment. [3]
Is an enhanced-delivery product better?
It may change exposure, but higher exposure does not automatically improve a clinical outcome or safety. Finished-product human comparisons are needed.
Can food provide fisetin?
Some foods contain fisetin, but amounts vary and do not reproduce concentrated supplement trials. Food intake and capsule dosing should not be treated as equivalent.
Glossary
Plain explanations of fisetin research terms.
- Flavonol
- A subgroup of plant polyphenols that includes fisetin and quercetin.
- Senescent cell
- A cell that has stopped dividing and can retain biologically active signalling.
- Senolytic
- An intervention studied for selectively reducing certain senescent cells.
- Senomorphic
- An intervention studied for changing harmful senescence-associated signalling without necessarily eliminating the cell.
- Explant
- Living tissue studied outside the body; it is human tissue evidence, not a clinical trial in a person.
- IL-8
- An inflammatory signalling molecule measured in the small colorectal-cancer trial.
How this guide was researched
The displayed PubMed title and authors were checked for each PMID. The completed human schedule was extracted as amount per administration, daily total, frequency, duration and treatment context. The dasatinib-plus-quercetin pilot at PMID 40010154 was excluded because it did not test fisetin.
Research record · checked October 9, 2026
Fresh reads: the 2024 fisetin senotherapeutic review, the 2018 colorectal-cancer randomized trial and the 2018 primary preclinical senotherapeutic paper.
Identity verification: PMID 39384074, PMID 29541713 and PMID 30279143 were matched to displayed titles and authors.
Protocol extraction: 100 mg per administration, 100 mg/day, once daily for seven weeks, beginning before chemotherapy, remains tied to the original population.
Excluded evidence: the 2025 dasatinib-plus-quercetin pilot was not presented as fisetin evidence.
Negative findings: no established healthy-aging dose, human lifespan outcome or validated public pulse schedule was found.
Explore the sources
A fisetin-specific review, direct primary human and preclinical reports, and official identity and regulatory references.
Showing 5 sources
- 01
Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases. ↗
Fisetin-specific review
Preclinical promise and unresolved human pharmacokinetics, efficacy, safety and dose optimization.
- 02
Fisetin is a senotherapeutic that extends health and lifespan. ↗
Primary preclinical and ex vivo study
Selected cell systems, human adipose explants and mouse healthspan and lifespan findings; not a human oral trial.
- 03
Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. ↗
Randomized placebo-controlled trial
Exact 100 mg once-daily, seven-week adjunctive protocol and narrow inflammatory-marker findings in 37 patients.
- 04
PubChem Compound Summary: Fisetin ↗
Official compound record
Defined chemical identity and synonyms; not evidence of clinical efficacy.
- 05
FDA 101: Dietary Supplements ↗
Official regulatory guidance
Pre-market, interaction and medication-review boundaries for dietary supplements.
No matching sources
Try a different term or show the full list.
Editorial note
This guide keeps senolytic mechanisms, preclinical lifespan findings, a human inflammatory biomarker and unproven human longevity outcomes separate.